assay development, in vivo toxicology studies for IND applications, biodistribution studies (rodents) and xenograft animal models, gene expression analysis (mRNA levels by qPCR and protein expression by Western Blot), tissue-targeted in vivo RNAi and siRNA delivery services, transient and stable transfection, development of RNAi knockdown cell lines, anti-cancer compound testing (in vitro and in vivo), microfluidics-based liposome encapsulation (proteins, DNA, siRNA, small molecule), gene silencing and cell-based assay development (apoptosis, cell viability, cell cycle, ATP), microorganism ID and 16S sequencing, bacteria identification and bioinformatic analysis services.